The pace of vaccination in the U.S. has picked up since the beginning of 2021, and we're currently in a race to inoculate the adult population before new variants spread widely. But as shots make it into arms and the world begins to reopen, we still have more to learn about how the coronavirus infects and spreads throughout a population almost 75 million strong: children. Clinical studies of vaccines from companies like Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are currently investigating adequate dosage and safety profiles. But in terms of a timeline, when could we start to think about vaccinating children against COVID-19? 10 stocks we like better than PfizerWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Pfizer wasn't one of them! That's right -- they think these 10 stocks are even better buys. See the 10 stocks *Stock Advisor returns as of February 24, 2021 Morgan McSweeney has no position in any of the stocks mentioned. The Motley Fool recommends Moderna Inc.. The Motley Fool has a disclosure policy.Source